MAP3K7 and hepatocellular carcinoma: Among the screened AS targets closely related to HCC progression, TGF‐β‐activated kinase 1 (TAK1, also known as MAP3K7) attracted our attention because of its potential role in the regulating of p38MAPK signaling.